The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 11, 2021

Filed:

May. 17, 2016
Applicant:

Association for the Advancement of Tissue Engineering and Cell Based Technologies and Therapies—a4tec, Braga, PT;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61L 31/04 (2006.01); A61L 31/10 (2006.01); A61L 31/14 (2006.01); A61L 31/16 (2006.01); B29C 45/00 (2006.01); B29C 71/00 (2006.01); A61F 2/04 (2013.01); B29L 31/00 (2006.01);
U.S. Cl.
CPC ...
A61L 31/041 (2013.01); A61L 31/042 (2013.01); A61L 31/045 (2013.01); A61L 31/10 (2013.01); A61L 31/148 (2013.01); A61L 31/16 (2013.01); B29C 45/0001 (2013.01); B29C 71/0009 (2013.01); A61F 2/04 (2013.01); A61F 2002/048 (2013.01); A61F 2240/001 (2013.01); A61F 2250/0067 (2013.01); A61F 2250/0096 (2013.01); A61L 2430/22 (2013.01); B29K 2089/00 (2013.01); B29L 2031/753 (2013.01);
Abstract

Stents and methods for producing stents are provided. The stent includes a polymeric substrate comprised of 10-50% (w/w) of alginate and 45-85% (w/w) of gelatine and further includes a polymeric biodegradable resin for coating said polymeric substrate. The stent can also include a contrast agent. The stent can further include a crosslinking agent. The method for producing the stent includes dissolving the alginate and gelatine in water and stirring to obtain a polymeric substrate. The method also includes adding a crosslinking agent to the substrate, injecting the substrate into a mold to obtain the stent, placing the stent in a first alcohol solution, and placing the stent in a crosslinking agent solution. The method further includes placing the stent in a second alcohol solution, and a series of interchanging drying and immersing steps.


Find Patent Forward Citations

Loading…